Famciclovir NDC 33342-026

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-026Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0026Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
33342-026-07	33342002607	30 TABLET, FILM COATED in 1 BOTTLE (33342-026-07)Marketed from Jan 13, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Famciclovir
Generic name (nonproprietary): famciclovir
Active ingredients: Famciclovir — 500 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Macleods Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201022
Marketing start: Jan 13, 2012
Listing expires: Dec 31, 2026
Other FDA classes: DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
Identifiers: Product ID 33342-026_b783e311-5fb2-4ab3-b10a-36c87c2a7d5fSPL ID b783e311-5fb2-4ab3-b10a-36c87c2a7d5fSPL set ID eeeee9c4-8566-4100-8ca4-3df936a3365dRxCUI 198382, 199192, 199193UNII QIC03ANI02UPC 0333342026071, 0333342024077, 0333342025074
Pharmacologic class: Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342002607 followed by a unit qualifier and the quantity

Package 33342-0026-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 17, 2025.

Indications (excerpt from the label)

Famciclovir, a prodrug of penciclovir, is a deoxynucleoside analog DNA polymerase inhibitor indicated for: Immunocompetent Adult Patients ( 1.1 ) • Herpes labialis (cold sores) o Treatment of recurrent episodes • Genital herpes o Treatment of recurrent episodes o Suppressive therapy of recurrent episodes • Herpes zoster (shingles) Human Immunodeficiency Virus (HIV) -Infected Adult Patients ( 1.2 ) • Treatment of recurrent episodes of orolabial or genital herpes Limitation of Use The efficacy and safety of famciclovir tablets have not been established for: • Patients with first episode of genital herpes • Patients with ophthalmic zoster • Immunocompromised patients other than for the treatmen…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201022

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201022
Product	Strength	Form · route	Labeler	Product NDC
Famciclovir	Famciclovir 500 mg/1	Tablet, Film coatedOral	Proficient Rx LP	71205-609
Famciclovir	Famciclovir 500 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-2936
Famciclovir	Famciclovir 250 mg/1	Tablet, Film coatedOral	Macleods Pharmaceuticals Limited	33342-025
Famciclovir	Famciclovir 125 mg/1	Tablet, Film coatedOral	Macleods Pharmaceuticals Limited	33342-024